Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-04 09:15 am Purchase |
2021-12-31 | 13G | Blueprint Medicines Corporation BPMC |
WELLINGTON MANAGEMENT CO LLP | 3,477,325 5.910% |
2,440,695 (+235.45%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Blueprint Medicines Corporation BPMC |
BLACKROCK INC BLK |
5,336,874 9.100% |
280,711 (+5.55%) |
Filing History |
| 2021-02-16 12:23 pm Purchase |
2020-12-31 | 13G | Blueprint Medicines Corporation BPMC |
PRICE T ROWE ASSOCIATES INC | 3,687,766 6.600% |
334,199 (+9.97%) |
Filing History |
| 2021-02-10 10:39 am Purchase |
2020-12-31 | 13G | Blueprint Medicines Corporation BPMC |
VANGUARD GROUP INC | 5,186,512 9.310% |
818,528 (+18.74%) |
Filing History |
| 2021-02-08 10:17 am Sale |
2021-02-05 | 13G | Blueprint Medicines Corporation BPMC |
FMR CORP | 4,190,375 7.518% |
-917,344 (-17.96%) |
Filing History |
| 2021-02-03 2:14 pm Sale |
2020-12-31 | 13G | Blueprint Medicines Corporation BPMC |
WELLINGTON MANAGEMENT CO LLP | 1,036,630 1.860% |
-1,499,997 (-59.13%) |
Filing History |
| 2021-01-28 5:56 pm Purchase |
2020-12-31 | 13G | Blueprint Medicines Corporation BPMC |
BLACKROCK INC BLK |
5,056,163 9.100% |
799,043 (+18.77%) |
Filing History |